nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—autistic disorder	0.969	1	CbGaD
Oxaprozin—Clorazepate—GABRB3—autistic disorder	0.00145	0.113	CrCbGaD
Oxaprozin—Clorazepate—GABRA5—autistic disorder	0.00145	0.113	CrCbGaD
Oxaprozin—Clorazepate—GABRA3—autistic disorder	0.00142	0.111	CrCbGaD
Oxaprozin—Clorazepate—GABRB2—autistic disorder	0.00127	0.0987	CrCbGaD
Oxaprozin—Clorazepate—GABRA1—autistic disorder	0.00124	0.0968	CrCbGaD
Oxaprozin—Clorazepate—GABRA2—autistic disorder	0.00119	0.0926	CrCbGaD
Oxaprozin—Bifonazole—CYP19A1—autistic disorder	0.00112	0.0873	CrCbGaD
Oxaprozin—Methadone—HTR3A—autistic disorder	0.000971	0.0756	CrCbGaD
Oxaprozin—Fenbufen—PTGS2—autistic disorder	0.000753	0.0586	CrCbGaD
Oxaprozin—Methadone—OPRM1—autistic disorder	0.000699	0.0544	CrCbGaD
Oxaprozin—Methadone—CYP19A1—autistic disorder	0.000494	0.0385	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS2—autistic disorder	0.000433	0.0337	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS2—autistic disorder	0.000353	0.0275	CrCbGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.000132	0.00723	CbGpPWpGaD
Oxaprozin—PTGS2—Arachidonic acid metabolism—GPX1—autistic disorder	0.000132	0.00723	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—MAOB—autistic disorder	0.000126	0.00687	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—autistic disorder	0.000125	0.00686	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.000124	0.0068	CbGpPWpGaD
Oxaprozin—PTGS2—S1P1 pathway—MAPK1—autistic disorder	0.00012	0.00654	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—CAT—autistic disorder	0.000117	0.00641	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—IL6—autistic disorder	0.000116	0.00633	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—autistic disorder	0.000111	0.0061	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM5—autistic disorder	0.000107	0.00585	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—GPX1—autistic disorder	0.000106	0.00579	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM5—autistic disorder	0.000105	0.00577	CbGpPWpGaD
Oxaprozin—PTGS1—Arachidonic acid metabolism—PTGS2—autistic disorder	9.8e-05	0.00536	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—MTHFR—autistic disorder	9.77e-05	0.00535	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	9.68e-05	0.0053	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—CAT—autistic disorder	9.3e-05	0.00509	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	9.29e-05	0.00508	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—IL6—autistic disorder	9.19e-05	0.00503	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	9.17e-05	0.00501	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—PLA2G4A—autistic disorder	9.14e-05	0.005	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—GSTM1—autistic disorder	9.11e-05	0.00498	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—GPX1—autistic disorder	8.75e-05	0.00479	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—POMC—autistic disorder	8.61e-05	0.00471	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—GPX1—autistic disorder	8.41e-05	0.0046	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—autistic disorder	8.11e-05	0.00444	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—GJA1—autistic disorder	8.01e-05	0.00438	CbGpPWpGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—autistic disorder	7.83e-05	0.00428	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—MTHFR—autistic disorder	7.76e-05	0.00424	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	7.69e-05	0.00421	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP19A1—autistic disorder	7.61e-05	0.00416	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—autistic disorder	7.6e-05	0.00416	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	7.53e-05	0.00412	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—BDNF—autistic disorder	7.27e-05	0.00398	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—autistic disorder	7.21e-05	0.00394	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SERPINE1—autistic disorder	7.14e-05	0.00391	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—COMT—autistic disorder	7.07e-05	0.00387	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTP1—autistic disorder	7.04e-05	0.00385	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—MAOA—autistic disorder	7.02e-05	0.00384	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	6.95e-05	0.0038	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL4—autistic disorder	6.75e-05	0.00369	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—MAOB—autistic disorder	6.6e-05	0.00361	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IFNG—autistic disorder	6.5e-05	0.00356	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTM1—autistic disorder	6.47e-05	0.00354	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—PTGS2—autistic disorder	6.23e-05	0.00341	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	6.13e-05	0.00335	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ACADSB—autistic disorder	6.05e-05	0.00331	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—INPP1—autistic disorder	6.05e-05	0.00331	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—autistic disorder	5.9e-05	0.00323	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—LEP—autistic disorder	5.71e-05	0.00313	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SERPINE1—autistic disorder	5.67e-05	0.0031	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	5.58e-05	0.00305	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—BCL2—autistic disorder	5.41e-05	0.00296	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AR—autistic disorder	5.4e-05	0.00296	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BTD—autistic disorder	5.39e-05	0.00295	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—NOS2—autistic disorder	5.32e-05	0.00291	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IFNG—autistic disorder	5.16e-05	0.00282	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—PTGS2—autistic disorder	5.15e-05	0.00282	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—RORA—autistic disorder	5.15e-05	0.00282	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BTD—autistic disorder	5.11e-05	0.0028	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	5.09e-05	0.00279	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	4.95e-05	0.00271	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	4.86e-05	0.00266	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACADSB—autistic disorder	4.81e-05	0.00263	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—INPP1—autistic disorder	4.81e-05	0.00263	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	4.73e-05	0.00259	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	4.72e-05	0.00258	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TDO2—autistic disorder	4.59e-05	0.00251	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—POMC—autistic disorder	4.57e-05	0.0025	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—autistic disorder	4.53e-05	0.00248	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DHCR7—autistic disorder	4.31e-05	0.00236	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BTD—autistic disorder	4.28e-05	0.00234	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC6A8—autistic disorder	4.09e-05	0.00224	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—EXT1—autistic disorder	4.09e-05	0.00224	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	4.09e-05	0.00224	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IFNG—autistic disorder	4.08e-05	0.00223	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP19A1—autistic disorder	4e-05	0.00219	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP19A1—autistic disorder	3.95e-05	0.00216	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DAO—autistic disorder	3.9e-05	0.00213	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EXT1—autistic disorder	3.88e-05	0.00212	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—UPB1—autistic disorder	3.74e-05	0.00205	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—COMT—autistic disorder	3.72e-05	0.00203	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTP1—autistic disorder	3.7e-05	0.00202	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—MAOA—autistic disorder	3.69e-05	0.00202	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—COMT—autistic disorder	3.67e-05	0.00201	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTP1—autistic disorder	3.65e-05	0.002	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TDO2—autistic disorder	3.64e-05	0.00199	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—autistic disorder	3.63e-05	0.00198	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	3.51e-05	0.00192	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ASMT—autistic disorder	3.48e-05	0.0019	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM5—autistic disorder	3.48e-05	0.0019	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	3.47e-05	0.0019	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DHCR7—autistic disorder	3.42e-05	0.00187	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM1—autistic disorder	3.4e-05	0.00186	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—autistic disorder	3.4e-05	0.00186	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	3.35e-05	0.00184	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC25A12—autistic disorder	3.27e-05	0.00179	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—EXT1—autistic disorder	3.25e-05	0.00178	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC6A8—autistic disorder	3.25e-05	0.00178	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	3.22e-05	0.00176	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	3.21e-05	0.00176	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—INPP1—autistic disorder	3.18e-05	0.00174	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACADSB—autistic disorder	3.18e-05	0.00174	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC19A1—autistic disorder	3.18e-05	0.00174	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC25A12—autistic disorder	3.1e-05	0.00169	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DAO—autistic disorder	3.1e-05	0.00169	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC19A1—autistic disorder	3.01e-05	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—UPB1—autistic disorder	2.97e-05	0.00162	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	2.92e-05	0.0016	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.92e-05	0.0016	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BTD—autistic disorder	2.84e-05	0.00155	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ADSL—autistic disorder	2.83e-05	0.00155	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	2.8e-05	0.00153	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—XDH—autistic disorder	2.78e-05	0.00152	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	2.78e-05	0.00152	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM5—autistic disorder	2.76e-05	0.00151	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ASMT—autistic disorder	2.76e-05	0.00151	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NPAS2—autistic disorder	2.73e-05	0.00149	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—STX1A—autistic disorder	2.73e-05	0.00149	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	2.71e-05	0.00148	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	2.7e-05	0.00148	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TCN2—autistic disorder	2.63e-05	0.00144	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC25A12—autistic disorder	2.59e-05	0.00142	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STX1A—autistic disorder	2.59e-05	0.00141	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC19A1—autistic disorder	2.52e-05	0.00138	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ADA—autistic disorder	2.51e-05	0.00137	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TCN2—autistic disorder	2.5e-05	0.00137	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.48e-05	0.00136	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—WNT2—autistic disorder	2.42e-05	0.00132	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TDO2—autistic disorder	2.41e-05	0.00132	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—autistic disorder	2.4e-05	0.00132	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.38e-05	0.0013	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	2.32e-05	0.00127	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.32e-05	0.00127	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RORA—autistic disorder	2.29e-05	0.00125	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DHCR7—autistic disorder	2.27e-05	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ADSL—autistic disorder	2.25e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—XDH—autistic disorder	2.21e-05	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—STX1A—autistic disorder	2.17e-05	0.00118	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NPAS2—autistic disorder	2.17e-05	0.00118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—EXT1—autistic disorder	2.15e-05	0.00118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC6A8—autistic disorder	2.15e-05	0.00118	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MAOB—autistic disorder	2.15e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—autistic disorder	2.13e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TCN2—autistic disorder	2.09e-05	0.00114	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DAO—autistic disorder	2.05e-05	0.00112	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.04e-05	0.00112	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TPH2—autistic disorder	2e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL10—autistic disorder	2e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ADA—autistic disorder	2e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.97e-05	0.00108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UPB1—autistic disorder	1.97e-05	0.00108	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DPYD—autistic disorder	1.96e-05	0.00107	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.89e-05	0.00103	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	1.89e-05	0.00103	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.84e-05	0.00101	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM5—autistic disorder	1.83e-05	0.001	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ASMT—autistic disorder	1.83e-05	0.001	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CACNA1C—autistic disorder	1.83e-05	0.000999	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RORA—autistic disorder	1.82e-05	0.000995	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.76e-05	0.000961	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC25A12—autistic disorder	1.72e-05	0.00094	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MAOB—autistic disorder	1.7e-05	0.000933	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC19A1—autistic disorder	1.67e-05	0.000914	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DHFR—autistic disorder	1.66e-05	0.000909	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.62e-05	0.000888	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TPH2—autistic disorder	1.59e-05	0.000867	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—DHFR—autistic disorder	1.57e-05	0.000862	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DPYD—autistic disorder	1.56e-05	0.000853	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.54e-05	0.00084	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADSL—autistic disorder	1.49e-05	0.000815	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.46e-05	0.000801	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—XDH—autistic disorder	1.46e-05	0.000799	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CACNA1C—autistic disorder	1.45e-05	0.000793	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—STX1A—autistic disorder	1.43e-05	0.000785	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NPAS2—autistic disorder	1.43e-05	0.000785	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALCA—autistic disorder	1.42e-05	0.000775	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.4e-05	0.000766	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.39e-05	0.000763	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TCN2—autistic disorder	1.39e-05	0.000758	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADA—autistic disorder	1.32e-05	0.000723	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DHFR—autistic disorder	1.32e-05	0.000722	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.31e-05	0.000714	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP19A1—autistic disorder	1.3e-05	0.000712	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRL—autistic disorder	1.25e-05	0.000685	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.25e-05	0.000684	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.22e-05	0.000668	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—COMT—autistic disorder	1.21e-05	0.000662	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RORA—autistic disorder	1.2e-05	0.000659	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—autistic disorder	1.2e-05	0.000659	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MAOA—autistic disorder	1.2e-05	0.000657	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAT—autistic disorder	1.17e-05	0.000641	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MAOB—autistic disorder	1.13e-05	0.000618	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—autistic disorder	1.11e-05	0.000605	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G4A—autistic disorder	1.11e-05	0.000605	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.07e-05	0.000588	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPX1—autistic disorder	1.06e-05	0.00058	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TPH2—autistic disorder	1.05e-05	0.000574	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP19A1—autistic disorder	1.03e-05	0.000565	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DPYD—autistic disorder	1.03e-05	0.000565	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—autistic disorder	9.78e-06	0.000535	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	9.7e-06	0.000531	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	9.7e-06	0.00053	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—COMT—autistic disorder	9.6e-06	0.000525	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CACNA1C—autistic disorder	9.6e-06	0.000525	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—autistic disorder	9.56e-06	0.000523	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MAOA—autistic disorder	9.54e-06	0.000522	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAT—autistic disorder	9.3e-06	0.000509	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—autistic disorder	9.27e-06	0.000507	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HLA-A—autistic disorder	9.24e-06	0.000506	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	9.23e-06	0.000505	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOE—autistic disorder	9.1e-06	0.000498	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TSC2—autistic disorder	8.82e-06	0.000482	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G4A—autistic disorder	8.78e-06	0.000481	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—autistic disorder	8.78e-06	0.000481	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DHFR—autistic disorder	8.73e-06	0.000478	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOE—autistic disorder	8.63e-06	0.000472	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPX1—autistic disorder	8.41e-06	0.00046	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—autistic disorder	8.22e-06	0.000449	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS2—autistic disorder	8.04e-06	0.00044	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—autistic disorder	7.82e-06	0.000428	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—autistic disorder	7.79e-06	0.000426	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—autistic disorder	7.76e-06	0.000425	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—autistic disorder	7.7e-06	0.000421	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.36e-06	0.000403	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOE—autistic disorder	7.23e-06	0.000395	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP19A1—autistic disorder	6.84e-06	0.000374	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—autistic disorder	6.77e-06	0.00037	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—autistic disorder	6.52e-06	0.000357	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.42e-06	0.000351	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—COMT—autistic disorder	6.36e-06	0.000348	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—autistic disorder	6.33e-06	0.000346	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MAOA—autistic disorder	6.31e-06	0.000345	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—autistic disorder	6.24e-06	0.000341	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—autistic disorder	6.21e-06	0.00034	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAT—autistic disorder	6.16e-06	0.000337	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—autistic disorder	5.82e-06	0.000318	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G4A—autistic disorder	5.82e-06	0.000318	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX1—autistic disorder	5.57e-06	0.000305	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—autistic disorder	5.44e-06	0.000298	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—autistic disorder	5.16e-06	0.000282	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—autistic disorder	5.14e-06	0.000281	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOE—autistic disorder	4.79e-06	0.000262	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—autistic disorder	4.32e-06	0.000236	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—autistic disorder	4.32e-06	0.000236	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK1—autistic disorder	4.19e-06	0.000229	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—autistic disorder	4.11e-06	0.000225	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—autistic disorder	3.37e-06	0.000184	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—autistic disorder	3.28e-06	0.000179	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—autistic disorder	3.22e-06	0.000176	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—autistic disorder	2.86e-06	0.000156	CbGpPWpGaD
